Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jgs.16551 | DOI Listing |
J Med Internet Res
January 2025
Institute of Learning Sciences and Technologies, National Tsing Hua University, Hsinchu, Taiwan.
Background: Health misinformation undermines responses to health crises, with social media amplifying the issue. Although organizations work to correct misinformation, challenges persist due to reasons such as the difficulty of effectively sharing corrections and information being overwhelming. At the same time, social media offers valuable interactive data, enabling researchers to analyze user engagement with health misinformation corrections and refine content design strategies.
View Article and Find Full Text PDFFront Public Health
January 2025
College of Economics and Management, Nanjing University of Science and Technology, Nanjing, Jiangsu, China.
Despite the increasing demand for sustainable development of pharmaceutical companies due to the rigorous pressure of environmental regulation, public health crisis and economic competition, there has been little research on relevant evaluation models. The COVID-19 experience has also prompted investors in pharmaceutical companies to re-examine the impact of environment and ethics on business development. Therefore, pharmaceutical companies need to focus on their performance, especially on the shift from a single financial performance to an integrated performance.
View Article and Find Full Text PDFLancet Respir Med
January 2025
Surveillance and Prevention Branch, Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Immun Inflamm Dis
December 2024
Department of Pathology, Moi University, Eldoret, Kenya.
Introduction: There are few accurate prognostic indications of the illness's development and severity for COVID-19, despite certain biomarkers having been investigated. The unexpected nature of COVID-19's course, which can quickly progress from asymptomatic to life-threatening symptoms, lies at the heart of the disease's intricacy. Predicting SARS-CoV-2 pathogenicity through laboratory biomarkers and as such, identifying the patients' illness severity at the time of their initial admission would be crucial in improving patient care.
View Article and Find Full Text PDFInt J Health Policy Manag
December 2024
Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
In this paper we draw upon the review article "Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons from the First Two Years of the Pandemic" by Saulnier et al to propose some additional themes to be considered regarding ongoing conversations on health system resilience. Complementing the lessons learned brought forward in the article, we propose three thematic areas which may enrichen this conversation. These three themes are posed as questions: (1) Transformation - towards what? (2) Crises and shocks - what counts as such? and (3) Levels and scales - can tensions be reconciled? While our insights are strongly rooted in research results on health system resilience during COVID-19 in Finland, we seek to discuss their wider implications for health system resilience and beyond the context of a single country.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!